Stock Market Decline Amid Rising Oil Prices and Tariff Concerns

Market Overview

On Wednesday, July 22, stock markets experienced a significant downturn. The Sensex fell by 715.06 points, closing at 76,755.05, while the Nifty dropped 191.45 points to finish at 23,996.25. Major contributors to this decline included the entire IT sector, with nearly 40 Nifty stocks plummeting by up to 4 percent, including key banking stocks.

Oil prices surged by approximately 4 percent, with Brent Crude surpassing $95 per barrel, driven by escalating tensions between the US and Iran. Additionally, the Indian rupee depreciated by 33 paise, settling at 96.57 against the dollar, compared to the previous day's close of 96.24.

The heightened conflict between the US and Iran, coupled with rising crude oil prices, has negatively impacted investor confidence. Analysts suggest that the market's mood has also been affected by new tariff threats from the US. On the same day, President Donald Trump announced a 100% tariff on all generic drugs imported into the US, effective August 1, 2028, which will increase to 200% the following year.

This announcement led to a decline in pharmaceutical shares, with the Nifty Pharma Index dropping nearly 2% during intraday trading and ultimately closing down over 1%. G. Chokkalingam, Head of Research at Equinomics Research, commented that investors in pharmaceutical stocks should not be overly concerned about Trump's proposed tariff plan. He noted that the two-year timeframe allows Indian companies to establish operations in the US, which may mitigate the impact of these tariffs. Chokkalingam also pointed out that by the time the grace period ends, Trump's presidency may be nearing its conclusion, and a new administration might not pursue such aggressive tariff policies, as high tariffs could significantly increase costs for US households.